Drug recall
Vyvanse (lisdexamfetamine dimesylate) Capsules 30 mg, 100 count bottle, Rx Only, Manufactured for: Shire US…
FDA recall event 75170 · Class III · Shire
Key facts
| Event ID | 75170 |
|---|---|
| Recall numbers | D-0006-2017 |
| Recalling firm | Shire |
| Product type | Drugs |
| Products | Vyvanse (lisdexamfetamine dimesylate) Capsules 30 mg, 100 count bottle, Rx Only, Manufactured for: Shire US, Inc., Lexington, MA 02421, NDC 59417-103-10 |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Presence of Foreign Tablets/Capsules |
| Initiation date | Sep 2, 2016 |
| Report date | Oct 12, 2016 |
| Termination date | Mar 8, 2019 |
| City | Chesterbrook |
| State | PA |
| Country | United States |
| FEI number | 3001237683 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: